amr global situation and...
TRANSCRIPT
![Page 1: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/1.jpg)
AMR Global Situation
and Strategy
Disease Control and Prevention Center
National Center for Global Health and Medicine
(WHO Collaboration Center)
Shinichiro Morioka, M.D.
![Page 2: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/2.jpg)
![Page 3: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/3.jpg)
![Page 4: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/4.jpg)
Alexander Fleming (1881-1955)
http://www.time.com/time/specials/2007/article/0,28804,1677329_1677708_1677828,00.html
It is not difficult to make microbes resistant to penicillin
in the laboratory by exposing them to concentrations not
sufficient to kill them, and the same thing has
occasionally happened in the body.
Nobel Lecture, December 11, 1945
![Page 5: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/5.jpg)
Resistance: Tackling a crisis for the health and wealth of nationsThe Review on Antimicrobial Resistance Chaired by Jim O’Neill (December 2014)
![Page 6: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/6.jpg)
Resistance: Tackling a crisis for the health and wealth of nationsThe Review on Antimicrobial Resistance Chaired by Jim O’Neill (December 2014)
![Page 7: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/7.jpg)
Antibiotic Use in Medical Care
![Page 8: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/8.jpg)
![Page 9: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/9.jpg)
Antibiotic use and AMR from 1990-2000 in selected countries
WHO: The evolving threat of antimicrobial resistance, Options for action (2012)
![Page 10: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/10.jpg)
The more antibiotics,
the more resistant bacteria.
![Page 11: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/11.jpg)
Global antibiotic use by class,2000-2010
State of the World’s Antibiotics, 2015.
CDDEP: Washington, D.C.
![Page 12: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/12.jpg)
Percentage change in antibiotic consumption
per capita 2000–2010, by country
State of the World’s Antibiotics, 2015. CDDEP: Washington, D.C.
![Page 13: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/13.jpg)
Carbapenem retail sales in selected countries,
2005–2010 (per 1,000 population)
Lancet Infect Dis 2013;13:1057-98
India
Pakistan
Egypt
![Page 14: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/14.jpg)
Antibiotic pipeline
WHO “The evolving threat of antimicrobial resistance Options for action” (2012)
![Page 15: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/15.jpg)
(https://www.cdc.gov/drugresistance/pdf/11-2013-508.pdf)
![Page 16: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/16.jpg)
http://www.theweek.in/features/lifestyle/India-war-against-over-the-counter-antibiotic-abuse.html
![Page 17: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/17.jpg)
Antibiotic Use in Livestock
![Page 18: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/18.jpg)
Estimated Annual Antibiotic Use
in the United States.
N Engl J Med 2013; 369:2474-2476
![Page 19: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/19.jpg)
Antibiotic consumption in livestock, ten top countries 2010-2030
State of the World’s Antibiotics, 2015. CDDEP: Washington, D.C.
![Page 20: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/20.jpg)
![Page 21: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/21.jpg)
Resistant bacteria in environment
![Page 22: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/22.jpg)
Dissemination of NDM-1 positive bacteria in the New Delhi environment
Walsh TR et al. Lancet Infect Dis. 2011;11:355-62.
![Page 23: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/23.jpg)
![Page 24: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/24.jpg)
![Page 25: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/25.jpg)
2015
![Page 26: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/26.jpg)
Collaboration under
One Health Approach
National Action Plan on Antimicrobial resistance (AMR) 2016-2020
![Page 27: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/27.jpg)
![Page 28: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/28.jpg)
Field
1 Public awareness/education
2 Surveillance/monitoring
3 Infection prevention/control
4 Proper use of antimicrobial agents
5 Research & development/drug development
6 International cooperation
National Action Plan on Antimicrobial resistance (AMR) 2016-2020
![Page 29: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/29.jpg)
Proportion of resistant isolates of specific indicator microorganisms
Indicator 2014 2020 (target)
Hu
man
Proportion of penicillin-resistance in
Streptococcus pneumoniae48% 15% or less
Proportion of fluoroquinolone resistance in
Escherichia coli45% 25% or less
Proportion of methicillin resistance in
Staphylococcus aureus51% 20% or less
Proportion of carbapenem resistance in
Pseudomonas aeruginosa17% 10% or less
Proportion of carbapenem resistance in
Escherichia coli/Klebsiella pneumoniae
0.1-
0.2%0.2% or less
(same level as of 2014)
Numeral targets
National Action Plan on Antimicrobial resistance (AMR) 2016-2020
![Page 30: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/30.jpg)
Surveillance is important.
No measurement, no management.
![Page 31: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/31.jpg)
AMR Clinical Reference Center
• Established in National Center for Global Health and
Medicine Hospital in April 2017
• Working on projects and researches based on National
Action Plan on Antimicrobial Resistance in Japan
– Clinical Surveillance Division
– Information and Education Division
![Page 32: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/32.jpg)
http://amr.ncgm.go.jp/
![Page 33: AMR Global Situation and Strategydcc.ncgm.go.jp/activity/Global_Health/2018/pdf/AMR_global_situation_and_strategy.pdfThe Review on Antimicrobial Resistance Chaired by Jim O’Neill](https://reader033.vdocument.in/reader033/viewer/2022042312/5edbbdc8ad6a402d66661ba3/html5/thumbnails/33.jpg)